CN108976198A - A kind of synthetic method of 3- (4- pyridine) Benzazole compounds - Google Patents

A kind of synthetic method of 3- (4- pyridine) Benzazole compounds Download PDF

Info

Publication number
CN108976198A
CN108976198A CN201811073559.1A CN201811073559A CN108976198A CN 108976198 A CN108976198 A CN 108976198A CN 201811073559 A CN201811073559 A CN 201811073559A CN 108976198 A CN108976198 A CN 108976198A
Authority
CN
China
Prior art keywords
pyridine
compound
added
ethyl acetate
benzazole compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201811073559.1A
Other languages
Chinese (zh)
Other versions
CN108976198B (en
Inventor
高庆贺
刘兴霞
原焕
王亚坤
仝培源
申昊天
张志昂
张伟荣
张积霞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xinxiang Medical University
Original Assignee
Xinxiang Medical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xinxiang Medical University filed Critical Xinxiang Medical University
Priority to CN201811073559.1A priority Critical patent/CN108976198B/en
Publication of CN108976198A publication Critical patent/CN108976198A/en
Application granted granted Critical
Publication of CN108976198B publication Critical patent/CN108976198B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

The invention discloses a kind of synthetic methods of 3- (4- pyridine) Benzazole compounds, belong to technical field of organic synthesis.A kind of technical solution of the present invention main points are as follows: synthetic method of 3- (4- pyridine) Benzazole compounds; specific steps are as follows: acetic acid oxime ester compound and 3- formyl indole or derivatives thereof are dissolved in solvent; then catalyst and nitrogenous organic base is added, is reacted in seal pipe in 100-130 DEG C and 3- (4- pyridine) Benzazole compounds is made.Synthesis process of the present invention is simple and efficient, by the way that 3- (4- pyridine) Benzazole compounds are directly made without one pot of transition metal-catalyzed one step of tandem reaction, it avoids due to the use of plurality of reagents in multistep reaction and to the wasting of resources and environmental pollution caused by purification process of each step reaction intermediate etc., raw material is easily prepared, reaction condition is mild, wide application range of substrates.

Description

A kind of synthetic method of 3- (4- pyridine) Benzazole compounds
Technical field
The invention belongs to technical field of organic synthesis, and in particular to a kind of synthesis side of 3- (4- pyridine) Benzazole compounds Method.
Background technique
Studies have shown that 3- (4- pyridine) indole derivatives have significant bioactivity, it is that potential inosine monophosphate is de- Hydrogen enzyme, Rho- kinase inhibitor and anti-malignant cell proliferation therapeutic agent have important application in biology and medicine and other fields Value.And the synthetic method of presently relevant 3- reported in the literature (4- pyridine) Benzazole compounds mainly passes through palladium chtalyst Suzuki coupling reaction, metal catalytic alkynes cycloaddition reaction andMade from reaction.These literature methods have make The disadvantages of with expensive catalyst, substrate narrow application range, severe reaction conditions and low yield, which greatly limits The application of such synthetic method in actual production.Therefore, the importance in view of 3- (4- pyridine) Benzazole compounds and existing The deficiency of synthetic method, the synthetic method for developing simple and direct, efficient such compound are very necessary.
Summary of the invention
The technical problem to be solved by the present invention is to provide a kind of starting materials simply easily to prepare, wide application range of substrates, area Field selectivity is high, reaction condition is mild and the synthetic method of 3- (4- pyridine) Benzazole compounds easy to operate.
The present invention adopts the following technical scheme that solve above-mentioned technical problem, a kind of 3- (4- pyridine) Benzazole compounds Synthetic method, it is characterised in that specific steps are as follows: be dissolved in acetic acid oxime ester compound 1 and 3- formyl indole class compound 2 In solvent, catalyst and nitrogenous organic base is then added, is reacted in seal pipe in 100-130 DEG C and target product 3- (4- is made Pyridine) Benzazole compounds 3, the reaction equation in the synthetic method are as follows:
Wherein R1For phenyl, substituted-phenyl, 2- naphthalene or thienyl, the substituted-phenyl be 3,4- methylenedioxyphenyl, 3,4- dichloride base phenyl or mono-substituted benzenes base, the substituent group on mono-substituted benzenes base phenyl ring are methyl, methoxyl group, nitro, chlorine Or bromine, R2For hydrogen, methyl, methoxyl group, methoxybenzyl, fluorine, chlorine, carbomethoxy or nitro, R3For hydrogen or methyl, solvent is toluene, chlorine Benzene, acetonitrile, Isosorbide-5-Nitrae-dioxane, tetrahydrofuran (THF) or n,N-Dimethylformamide (DMF), catalyst are elemental iodine, N- iodine For succimide or ammonium iodide, nitrogenous organic base is triethylamine, diethylamine, pyridine, Isosorbide-5-Nitrae-diazabicylo [2.2.2] octane (DABCO), 11 carbon -7- alkene (DBU) of 1,8- diazabicylo or quinoline.
Further preferably, the acetic acid oxime ester compound 1,3- formyl indole or derivatives thereof 2, catalyst with it is nitrogenous The molar ratio of organic base is 2:1:1:1, and the charge ratio of acetic acid oxime ester compound 1 and solvent is 1mmol:2mL.
The synthetic method of 3- (4- pyridine) Benzazole compounds of the present invention, it is characterised in that specific steps are as follows: will Acetic acid oxime ester compound 1l and 3- formyl indole 2a is dissolved in solvent Isosorbide-5-Nitrae-dioxane, and catalyst iodine simple substance is then added With nitrogenous organic base pyridine, is reacted in seal pipe in 110 DEG C and target product quinoline -4- Carbox amide 3l is made, it should Reaction equation in synthetic method are as follows:
Further preferably, acetic acid oxime ester compound 1l, 3- formyl indole 2a, catalyst iodine simple substance have with nitrogenous The molar ratio of machine alkali pyridine is 2:1:1:1, acetic acid oxime ester compound 1l and solvent Isosorbide-5-Nitrae-dioxane charge ratio For 1mmol:2mL.
Further preferably, 3- (4- pyridine) Benzazole compounds 3 are one of following compounds:
Compared with the prior art, the present invention has the following advantages: 1, synthesis process be without transition metal-catalyzed one pot series connection Reaction, process is simple, efficient, while avoiding due to the use of plurality of reagents in multistep reaction and to each step reaction intermediate Purification process etc. caused by the wasting of resources and environmental pollution;2, raw material is easily prepared;3, reaction condition is mild, easy to operate; 4, substrate is applied widely.Therefore, the present invention provides a kind of economical real for the synthesis of 3- (4- pyridine) Benzazole compounds With and environmentally protective new method.
Specific embodiment
Above content of the invention is described in further details by the following examples, but this should not be interpreted as to this The range for inventing above-mentioned theme is only limitted to embodiment below, and all technologies realized based on above content of the present invention belong to this hair Bright range.
Embodiment 1
Compound 1a (1.0mmol, 191mg), compound 2a (0.5mmol, 72.6mg), iodine are added in 25mL seal pipe Simple substance (0.5mmol, 127mg), pyridine (0.5mmol, 39.6mg) and Isosorbide-5-Nitrae-dioxane (2mL), are subsequently placed in 110 DEG C of oil baths In be stirred to react 12h.50mL water quenching reaction is added, (50mL × 3) are extracted with ethyl acetate, later organic phase mass concentration For 10% Na2S2O3Solution and saturated salt solution successively wash, and anhydrous sodium sulfate is dry.Filtering, is spin-dried for, and crosses silica gel post separation (petrol ether/ethyl acetate=10/1, v/v) obtains white solid product 3a (153.3mg, 82%).The characterization number of the compound According to as follows:1H NMR(400MHz,DMSO-d6): δ (ppm) 11.79 (s, 1H), 8.29 (d, J=2.8Hz, 1H), 8.21 (d, J= 8.0Hz, 4H), 8.15 (s, 2H), 8.13-8.08 (m, 1H), 7.58-7.50 (m, 1H), 7.36 (d, J=8.0Hz, 4H), 7.26–7.22(m,2H),2.39(s,6H);13C NMR(100MHz,DMSO-d6)δ(ppm)156.1,145.4,138.4, 137.2,136.5,129.3,126.7,126.5,124.8,121.9,120.5,119.3,115.0,113.4,112.3,20.9; HRMS(ESI):m/z[M+Na]+calcd for C27H22N2Na:397.1675;found:397.1676.
Embodiment 2
Compound 1a (1.0mmol, 191mg), compound 2a (0.5mmol, 72.6mg), iodine are added in 25mL seal pipe Simple substance (0.5mmol, 127mg), triethylamine (0.5mmol, 50.5mg) and chlorobenzene (2mL), are subsequently placed in 130 DEG C of oil baths and stir React 12h.50mL water quenching reaction is added, (50mL × 3) are extracted with ethyl acetate, organic phase mass concentration is 10% later Na2S2O3Solution and saturated salt solution successively wash, and anhydrous sodium sulfate is dry.Filtering, is spin-dried for, and crosses silica gel post separation (petroleum Ether/ethyl acetate=10/1, v/v) obtain white solid product 3a (121.6mg, 65%).
Embodiment 3
Compound 1a (1.0mmol, 191mg), compound 2a (0.5mmol, 72.6mg), iodine are added in 25mL seal pipe Simple substance (0.5mmol, 127mg), triethylamine (0.5mmol, 50.5mg) and toluene (2mL), are subsequently placed in 130 DEG C of oil baths and stir React 12h.50mL water quenching reaction is added, (50mL × 3) are extracted with ethyl acetate, organic phase mass concentration is 10% later Na2S2O3Solution and saturated salt solution successively wash, and anhydrous sodium sulfate is dry.Filtering, is spin-dried for, and crosses silica gel post separation (petroleum Ether/ethyl acetate=5/1, v/v) obtain white solid product 3a (112.2mg, 60%).
Embodiment 4
Compound 1a (1.0mmol, 191mg), compound 2a (0.5mmol, 72.6mg), iodine are added in 25mL seal pipe Simple substance (0.5mmol, 127mg), triethylamine (0.5mmol, 50.5mg) and Isosorbide-5-Nitrae-dioxane (2mL), are subsequently placed in 130 DEG C of oil 12h is stirred to react in bath.50mL water quenching reaction is added, (50mL × 3) are extracted with ethyl acetate, organic phase quality is dense later The Na that degree is 10%2S2O3Solution and saturated salt solution successively wash, and anhydrous sodium sulfate is dry.Filtering, is spin-dried for, and crosses silicagel column point White solid product 3a (142.1mg, 76%) is obtained from (petrol ether/ethyl acetate=5/1, v/v).
Embodiment 5
Compound 1a (1.0mmol, 191mg), compound 2a (0.5mmol, 72.6mg), iodine are added in 25mL seal pipe Simple substance (0.5mmol, 127mg), triethylamine (0.5mmol, 50.5mg) and acetonitrile (2mL), are subsequently placed in 130 DEG C of oil baths and stir React 12h.50mL water quenching reaction is added, (50mL × 3) are extracted with ethyl acetate, organic phase mass concentration is 10% later Na2S2O3Solution and saturated salt solution successively wash, and anhydrous sodium sulfate is dry.Filtering, is spin-dried for, and crosses silica gel post separation (petroleum Ether/ethyl acetate=5/1, v/v) obtain white solid product 3a (134.6mg, 72%).
Embodiment 6
Compound 1a (1.0mmol, 191mg), compound 2a (0.5mmol, 72.6mg), iodine are added in 25mL seal pipe Simple substance (0.5mmol, 127mg), triethylamine (0.5mmol, 50.5mg) and tetrahydrofuran (2mL), are subsequently placed in 130 DEG C of oil baths It is stirred to react 12h.50mL water quenching reaction is added, (50mL × 3) are extracted with ethyl acetate, organic phase is with mass concentration later 10% Na2S2O3Solution and saturated salt solution successively wash, and anhydrous sodium sulfate is dry.Filtering, is spin-dried for, and crosses silica gel post separation (stone Oily ether/ethyl acetate=5/1, v/v) obtain white solid product 3a (129mg, 69%).
Embodiment 7
Compound 1a (1.0mmol, 191mg), compound 2a (0.5mmol, 72.6mg), iodine are added in 25mL seal pipe Simple substance (0.5mmol, 127mg), triethylamine (0.5mmol, 50.5mg) and n,N-Dimethylformamide (2mL), are subsequently placed in 130 12h is stirred to react in DEG C oil bath.50mL water quenching reaction is added, (50mL × 3) are extracted with ethyl acetate, later organic phase matter Measure the Na that concentration is 10%2S2O3Solution and saturated salt solution successively wash, and anhydrous sodium sulfate is dry.Filtering, is spin-dried for, and crosses silica gel Post separation (petrol ether/ethyl acetate=5/1, v/v) obtains white solid product 3a (89.8mg, 48%).
Embodiment 8
Compound 1a (1.0mmol, 191mg), compound 2a (0.5mmol, 72.6mg), N- are added in 25mL seal pipe N-iodosuccinimide (0.5mmol, 112.5mg), triethylamine (0.5mmol, 50.5mg) and Isosorbide-5-Nitrae-dioxane (2mL), so It is placed in 130 DEG C of oil baths and is stirred to react 12h.50mL water quenching reaction is added, (50mL × 3) are extracted with ethyl acetate, later The Na that organic phase mass concentration is 10%2S2O3Solution and saturated salt solution successively wash, and anhydrous sodium sulfate is dry.Filtering, rotation It is dry, it crosses silica gel post separation (petrol ether/ethyl acetate=5/1, v/v) and obtains white solid product 3a (110.3mg, 59%).
Embodiment 9
Compound 1a (1.0mmol, 191mg), compound 2a (0.5mmol, 72.6mg), iodine are added in 25mL seal pipe Change ammonium (0.5mmol, 72.5mg), triethylamine (0.5mmol, 50.5mg) and Isosorbide-5-Nitrae-dioxane (2mL), is subsequently placed in 130 DEG C 12h is stirred to react in oil bath.50mL water quenching reaction is added, (50mL × 3) are extracted with ethyl acetate, later organic phase quality The Na that concentration is 10%2S2O3Solution and saturated salt solution successively wash, and anhydrous sodium sulfate is dry.Filtering, is spin-dried for, and crosses silicagel column Separation (petrol ether/ethyl acetate=5/1, v/v) obtains white solid product 3a (78.5mg, 42%).
Embodiment 10
Compound 1a (1.0mmol, 191mg), compound 2a (0.5mmol, 72.6mg), iodine are added in 25mL seal pipe Simple substance (0.5mmol, 127mg), diethylamine (0.5mmol, 36.6mg) and Isosorbide-5-Nitrae-dioxane (2mL), are subsequently placed in 130 DEG C of oil 12h is stirred to react in bath.50mL water quenching reaction is added, (50mL × 3) are extracted with ethyl acetate, organic phase quality is dense later The Na that degree is 10%2S2O3Solution and saturated salt solution successively wash, and anhydrous sodium sulfate is dry.Filtering, is spin-dried for, and crosses silicagel column point White solid product 3a (127.2mg, 68%) is obtained from (petrol ether/ethyl acetate=5/1, v/v).
Embodiment 11
Compound 1a (1.0mmol, 191mg), compound 2a (0.5mmol, 72.6mg), iodine are added in 25mL seal pipe Simple substance (0.5mmol, 127mg), 1,4- diazabicylo [2.2.2] octane (0.5mmol, 56mg) and 1,4- dioxane (2mL) is subsequently placed in 130 DEG C of oil baths and is stirred to react 12h.50mL water quenching reaction is added, be extracted with ethyl acetate (50mL × 3), the Na that organic phase mass concentration is 10% later2S2O3Solution and saturated salt solution successively wash, and anhydrous sodium sulfate is dry. Filtering, be spin-dried for, cross silica gel post separation (petrol ether/ethyl acetate=5/1, v/v) obtain white solid product 3a (119.7mg, 64%).
Embodiment 12
Compound 1a (1.0mmol, 191mg), compound 2a (0.5mmol, 72.6mg), iodine are added in 25mL seal pipe Simple substance (0.5mmol, 127mg), 11 carbon -7- alkene (0.5mmol, 76mg) of 1,8- diazabicylo and 1,4- dioxane (2mL) is subsequently placed in 130 DEG C of oil baths and is stirred to react 12h.50mL water quenching reaction is added, be extracted with ethyl acetate (50mL × 3), the Na that organic phase mass concentration is 10% later2S2O3Solution and saturated salt solution successively wash, and anhydrous sodium sulfate is dry. Filtering, be spin-dried for, cross silica gel post separation (petrol ether/ethyl acetate=5/1, v/v) obtain white solid product 3a (80.4mg, 43%).
Embodiment 13
Compound 1a (1.0mmol, 191mg), compound 2a (0.5mmol, 72.6mg), iodine are added in 25mL seal pipe Simple substance (0.5mmol, 127mg), quinoline (0.5mmol, 64.6mg) and Isosorbide-5-Nitrae-dioxane (2mL), are subsequently placed in 130 DEG C of oil baths In be stirred to react 12h.50mL water quenching reaction is added, (50mL × 3) are extracted with ethyl acetate, later organic phase mass concentration For 10% Na2S2O3Solution and saturated salt solution successively wash, and anhydrous sodium sulfate is dry.Filtering, is spin-dried for, and crosses silica gel post separation (petrol ether/ethyl acetate=5/1, v/v) obtains white solid product 3a (76.7mg, 41%).
Embodiment 14
Compound 1a (1.0mmol, 191mg), compound 2a (0.5mmol, 72.6mg), iodine are added in 25mL seal pipe Simple substance (0.5mmol, 127mg), pyridine (0.5mmol, 39.6mg) and Isosorbide-5-Nitrae-dioxane (2mL), are subsequently placed in 130 DEG C of oil baths In be stirred to react 12h.50mL water quenching reaction is added, (50mL × 3) are extracted with ethyl acetate, later organic phase mass concentration For 10% Na2S2O3Solution and saturated salt solution successively wash, and anhydrous sodium sulfate is dry.Filtering, is spin-dried for, and crosses silica gel post separation (petrol ether/ethyl acetate=5/1, v/v) obtains white solid product 3a (153.3mg, 82%).
Embodiment 15
Compound 1a (1.0mmol, 191mg), compound 2a (0.5mmol, 72.6mg), iodine are added in 25mL seal pipe Simple substance (0.5mmol, 127mg), pyridine (0.5mmol, 39.6mg) and Isosorbide-5-Nitrae-dioxane (2mL), are subsequently placed in 100 DEG C of oil baths In be stirred to react 12h.50mL water quenching reaction is added, (50mL × 3) are extracted with ethyl acetate, later organic phase mass concentration For 10% Na2S2O3Solution and saturated salt solution successively wash, and anhydrous sodium sulfate is dry.Filtering, is spin-dried for, and crosses silica gel post separation (petrol ether/ethyl acetate=5/1, v/v) obtains white solid product 3a (136.5mg, 73%).
Embodiment 16
Compound 1b (1.0mmol, 177mg), compound 2a (0.5mmol, 72.6mg), iodine are added in 25mL seal pipe Simple substance (0.5mmol, 127mg), pyridine (0.5mmol, 39.6mg) and Isosorbide-5-Nitrae-dioxane (2mL), are subsequently placed in 110 DEG C of oil baths In be stirred to react 12h.50mL water quenching reaction is added, (50mL × 3) are extracted with ethyl acetate, later organic phase mass concentration For 10% Na2S2O3Solution and saturated salt solution successively wash, and anhydrous sodium sulfate is dry.Filtering, is spin-dried for, and crosses silica gel post separation (petrol ether/ethyl acetate=10/1, v/v) obtains white solid product 3b (136.7mg, 79%).The characterization number of the compound According to as follows:1H NMR(400MHz,DMSO-d6): δ (ppm) 11.81 (s, 1H), 8.32 (d, J=7.6Hz, 5H), 8.22 (s, 2H), 8.14 (d, J=4.4Hz, 1H), 7.64-7.53 (m, 5H), 7.52-7.45 (m, 2H), 7.29-7.21 (m, 2H);13C NMR(100MHz,DMSO-d6)δ(ppm)156.3,145.6,139.2,137.2,129.0,128.7,126.8,126.6, 124.8,121.9,120.6,119.4,115.7,113.3,112.3;HRMS(ESI):m/z[M+H]+calcd for C25H19N2:347.1543;found:347.1545.
Embodiment 17
Compound 1c (1.0mmol, 207mg), compound 2a (0.5mmol, 72.6mg), iodine are added in 25mL seal pipe Simple substance (0.5mmol, 127mg), pyridine (0.5mmol, 39.6mg) and Isosorbide-5-Nitrae-dioxane (2mL), are subsequently placed in 110 DEG C of oil baths In be stirred to react 12h.50mL water quenching reaction is added, (50mL × 3) are extracted with ethyl acetate, later organic phase mass concentration For 10% Na2S2O3Solution and saturated salt solution successively wash, and anhydrous sodium sulfate is dry.Filtering, is spin-dried for, and crosses silica gel post separation (petrol ether/ethyl acetate=10/1, v/v) obtains white solid product 3c (180.6mg, 89%).The characterization number of the compound According to as follows:1H NMR(400MHz,DMSO-d6): δ (ppm) 11.78 (s, 1H), 8.27 (d, J=7.6Hz, 5H), 8.16-8.02 (m, 3H), 7.56 (d, J=5.6Hz, 1H), 7.25 (d, J=3.6Hz, 2H), 7.11 (d, J=8.4Hz, 4H), 3.83 (s, 6H);13C NMR(100MHz,DMSO-d6)δ(ppm)160.1,155.9,145.3,137.2,131.9,128.1,126.4, 124.9,121.9,120.5,119.4,114.2,114.1,113.6,112.4,55.2;HRMS(ESI):m/z[M+H]+calcd for C27H23N2O2:407.1754;found:407.1757.
Embodiment 18
Compound 1d (1.0mmol, 221mg), compound 2a (0.5mmol, 72.6mg), iodine are added in 25mL seal pipe Simple substance (0.5mmol, 127mg), pyridine (0.5mmol, 39.6mg) and Isosorbide-5-Nitrae-dioxane (2mL), are subsequently placed in 110 DEG C of oil baths In be stirred to react 12h.50mL water quenching reaction is added, (50mL × 3) are extracted with ethyl acetate, later organic phase mass concentration For 10% Na2S2O3Solution and saturated salt solution successively wash, and anhydrous sodium sulfate is dry.Filtering, is spin-dried for, and crosses silica gel post separation (petrol ether/ethyl acetate=10/1, v/v) obtains white solid product 3d (188.8mg, 87%).The characterization number of the compound According to as follows:1H NMR(400MHz,DMSO-d6):δ(ppm)11.76(s,1H),8.28(s,1H),8.10(s,1H),8.07(s, 2H), 7.87 (s, 3H), 8.84 (s, 1H), 7.53 (d, J=4.4Hz, 1H), 7.23 (d, J=2.8Hz, 2H), 7.08 (d, J= 7.6Hz,2H),6.12(s,4H);13C NMR(100MHz,DMSO-d6)δ(ppm)155.5,148.1,147.9,145.4, 137.2,133.7,126.5,124.8,121.9,120.9,120.5,119.5,114.7,113.4,112.3,108.4, 107.0,101.3;HRMS(ESI):m/z[M+H]+calcd for C27H19N2O4:435.1339;found:435.1338.
Embodiment 19
Compound 1e (1.0mmol, 222mg), compound 2a (0.5mmol, 72.6mg), iodine are added in 25mL seal pipe Simple substance (0.5mmol, 127mg), pyridine (0.5mmol, 39.6mg) and Isosorbide-5-Nitrae-dioxane (2mL), are subsequently placed in 110 DEG C of oil baths In be stirred to react 12h.50mL water quenching reaction is added, (50mL × 3) are extracted with ethyl acetate, later organic phase mass concentration For 10% Na2S2O3Solution and saturated salt solution successively wash, and anhydrous sodium sulfate is dry.Filtering, is spin-dried for, and crosses silica gel post separation (petrol ether/ethyl acetate=10/1, v/v) obtains white solid product 3e (154.7mg, 71%).The characterization number of the compound According to as follows:1H NMR(400MHz,DMSO-d6): δ (ppm) 11.84 (s, 1H), 9.03 (s, 2H), 8.70 (d, J=7.6Hz, 2H), 8.36 (d, J=2.8Hz, 1H), 8.34 (s, 2H), 8.31 (d, J=2.0Hz, 1H), 8.29 (d, J=2.0Hz, 1H), 8.12 (d, J=7.2Hz, 1H), 7.82 (t, J=8.0Hz, 2H), 7.55-7.50 (m, 1H), 7.28-7.18 (m, 2H);13C NMR(100MHz,DMSO-d6)δ(ppm)154.0,148.4,146.4,140.4,137.2,133.1,130.3,127.4, 124.6,123.7,122.0,121.2,120.6,119.5,116.9,112.7,112.3;HRMS(ESI):m/z[M+Na]+ calcd for C25H16N4NaO4:459.1064;found:459.1069.
Embodiment 20
Compound 1f (1.0mmol, 211mg), compound 2a (0.5mmol, 72.6mg), iodine are added in 25mL seal pipe Simple substance (0.5mmol, 127mg), pyridine (0.5mmol, 39.6mg) and Isosorbide-5-Nitrae-dioxane (2mL), are subsequently placed in 110 DEG C of oil baths In be stirred to react 12h.50mL water quenching reaction is added, (50mL × 3) are extracted with ethyl acetate, later organic phase mass concentration For 10% Na2S2O3Solution and saturated salt solution successively wash, and anhydrous sodium sulfate is dry.Filtering, is spin-dried for, and crosses silica gel post separation (petrol ether/ethyl acetate=10/1, v/v) obtains white solid product 3f (126.5mg, 61%).The characterization number of the compound According to as follows:1H NMR(400MHz,DMSO-d6):δ(ppm)11.89(s,1H),8.43(s,2H),8.40(s,3H),8.31(s, 2H), 8.23-8.18 (m, 1H), 7.68 (d, J=8.4Hz, 4H), 7.64-7.59 (m, 1H), 7.35-7.28 (m, 2H);13C NMR(100MHz,DMSO-d6)δ(ppm)155.0,145.9,137.8,137.2,133.9,128.7,128.6,126.9, 124.7,122.0,120.6,119.4,115.8,113.0,112.3;HRMS(ESI):m/z[M+H]+calcd for C25H17Cl2N2:415.0763;found:415.0764.
Embodiment 21
Compound 1g (1.0mmol, 256mg), compound 2a (0.5mmol, 72.6mg), iodine are added in 25mL seal pipe Simple substance (0.5mmol, 127mg), pyridine (0.5mmol, 39.6mg) and Isosorbide-5-Nitrae-dioxane (2mL), are subsequently placed in 110 DEG C of oil baths In be stirred to react 12h.50mL water quenching reaction is added, (50mL × 3) are extracted with ethyl acetate, later organic phase mass concentration For 10% Na2S2O3Solution and saturated salt solution successively wash, and anhydrous sodium sulfate is dry.Filtering, is spin-dried for, and crosses silica gel post separation (petrol ether/ethyl acetate=10/1, v/v) obtains white solid product 3g (161.3mg, 64%).The characterization number of the compound According to as follows:1H NMR(400MHz,DMSO-d6): δ (ppm) 11.81 (s, 1H), 8.31 (d, J=2.8Hz, 1H), 8.28-8.20 (m, 6H), 8.14-8.09 (m, 1H), 7.73 (d, J=8.4Hz, 4H), 7.56-7.51 (m, 1H), 7.28-7.19 (m, 2H);13C NMR(100MHz,DMSO-d6)δ(ppm)155.1,145.9,138.2,137.2,131.6,128.9,126.9,124.7, 122.7,122.0,120.6,119.4,115.8,113.0,112.4;HRMS(ESI):m/z[M+H]+calcd for C25H17Br2N2:502.9753;found:502.9758.
Embodiment 22
Compound 1h (1.0mmol, 246mg), compound 2a (0.5mmol, 72.6mg), iodine are added in 25mL seal pipe Simple substance (0.5mmol, 127mg), pyridine (0.5mmol, 39.6mg) and Isosorbide-5-Nitrae-dioxane (2mL), are subsequently placed in 110 DEG C of oil baths In be stirred to react 12h.50mL water quenching reaction is added, (50mL × 3) are extracted with ethyl acetate, later organic phase mass concentration For 10% Na2S2O3Solution and saturated salt solution successively wash, and anhydrous sodium sulfate is dry.Filtering, is spin-dried for, and crosses silica gel post separation (petrol ether/ethyl acetate=10/1, v/v) obtains white solid product 3h (167mg, 69%).The characterize data of the compound It is as follows:1H NMR(400MHz,DMSO-d6): δ (ppm) 11.81 (s, 1H), 8.43 (s, 2H), 8.30 (d, J=4.4Hz, 1H), 8.24-8.15 (m, 4H), 8.08 (d, J=7.2Hz, 1H), 7.74-7.67 (m, 2H), 7.52 (d, J=7.6Hz, 1H), 7.28- 7.17(m,2H);13C NMR(100MHz,DMSO-d6)δ(ppm)153.6,146.1,139.3,137.2,131.7,131.6, 130.7,128.4,127.2,126.8,124.6,121.9,120.5,119.5,116.3,112.8,112.3;HRMS(ESI): m/z[M+H]+calcd for C25H15Cl4N2:482.9984;found:482.9988.
Embodiment 23
Compound 1i (1.0mmol, 227mg), compound 2a (0.5mmol, 72.6mg), iodine are added in 25mL seal pipe Simple substance (0.5mmol, 127mg), pyridine (0.5mmol, 39.6mg) and Isosorbide-5-Nitrae-dioxane (2mL), are subsequently placed in 110 DEG C of oil baths In be stirred to react 12h.50mL water quenching reaction is added, (50mL × 3) are extracted with ethyl acetate, later organic phase mass concentration For 10% Na2S2O3Solution and saturated salt solution successively wash, and anhydrous sodium sulfate is dry.Filtering, is spin-dried for, and crosses silica gel post separation (petrol ether/ethyl acetate=10/1, v/v) obtains white solid product 3i (131.5mg, 59%).The characterization number of the compound According to as follows:1H NMR(400MHz,DMSO-d6): δ (ppm) 11.86 (s, 1H), 8.93 (s, 2H), 8.57 (d, J=8.4Hz, 2H), 8.43 (s, 2H), 8.40 (d, J=2.4Hz, 1H), 8.26-8.21 (m, 1H), 8.17 (d, J=7.2Hz, 2H), 8.12 (d, J=8.8Hz, 2H), 8.01 (d, J=6.8Hz, 2H), 7.63-7.55 (m, 5H), 7.32-7.25 (m, 2H);13C NMR (100MHz,DMSO-d6)δ(ppm)156.3,145.7,137.3,136.7,133.3,133.2,128.7,128.2,127.6, 126.7,126.6,126.4,126.1,124.8,122.0,120.6,119.5,116.2,113.4,112.4;HRMS(ESI): m/z[M+H]+calcd for C33H23N2:447.1856;found:447.1859.
Embodiment 24
Compound 1j (1.0mmol, 183mg), compound 2a (0.5mmol, 72.6mg), iodine are added in 25mL seal pipe Simple substance (0.5mmol, 127mg), pyridine (0.5mmol, 39.6mg) and Isosorbide-5-Nitrae-dioxane (2mL), are subsequently placed in 110 DEG C of oil baths In be stirred to react 12h.50mL water quenching reaction is added, (50mL × 3) are extracted with ethyl acetate, later organic phase mass concentration For 10% Na2S2O3Solution and saturated salt solution successively wash, and anhydrous sodium sulfate is dry.Filtering, is spin-dried for, and crosses silica gel post separation (petrol ether/ethyl acetate=10/1, v/v) obtains white solid product 3j (116.3mg, 65%).The characterization number of the compound According to as follows:1H NMR(400MHz,DMSO-d6):δ(ppm)11.82(s,1H),8.28(s,1H),8.19–8.05(m,3H), 7.98 (s, 2H), 7.66 (d, J=4.4Hz, 2H), 7.55 (d, J=5.2Hz, 1H), 7.29-7.10 (m, 4H);13C NMR (100MHz,DMSO-d6)δ(ppm)151.8,145.4,144.6,137.2,128.4,128.3,126.8,125.4,124.7, 122.0,120.6,119.5,113.5,112.7,112.4;HRMS(ESI):m/z[M+Na]+calcd for C21H14N2NaS2: 381.0491;found:381.0492.
Embodiment 25
Compound 1k (1.0mmol, 183mg), compound 2a (0.5mmol, 72.6mg), iodine are added in 25mL seal pipe Simple substance (0.5mmol, 127mg), pyridine (0.5mmol, 39.6mg) and Isosorbide-5-Nitrae-dioxane (2mL), are subsequently placed in 110 DEG C of oil baths In be stirred to react 12h.50mL water quenching reaction is added, (50mL × 3) are extracted with ethyl acetate, later organic phase mass concentration For 10% Na2S2O3Solution and saturated salt solution successively wash, and anhydrous sodium sulfate is dry.Filtering, is spin-dried for, and crosses silica gel post separation (petrol ether/ethyl acetate=10/1, v/v) obtains white solid product 3k (128.9mg, 72%).The characterization number of the compound According to as follows:1H NMR(400MHz,DMSO-d6): δ (ppm) 11.78 (s, 1H), 8.38 (d, J=2.0Hz, 2H), 8.25 (d, J= 2.8Hz, 1H), 8.16-8.12 (m, 1H), 8.08 (s, 2H), 7.97 (d, J=5.2Hz, 2H), 7.70-7.66 (m, 2H), 7.57–7.52(m,1H),7.29–7.19(m,2H);13C NMR(100MHz,DMSO-d6)δ(ppm)152.8,145.3, 142.4,137.2,126.8,126.7,126.5,124.8,124.2,121.9,120.5,119.6,115.1,113.1, 112.3;HRMS(ESI):m/z[M-H]-calcd for C21H13N2S2:357.0526;found:357.0521.
Embodiment 26
Compound 1l (1.0mmol, 203mg), compound 2a (0.5mmol, 72.6mg), iodine are added in 25mL seal pipe Simple substance (0.5mmol, 127mg), pyridine (0.5mmol, 39.6mg) and Isosorbide-5-Nitrae-dioxane (2mL), are subsequently placed in 110 DEG C of oil baths In be stirred to react 12h.50mL water quenching reaction is added, (50mL × 3) are extracted with ethyl acetate, later organic phase mass concentration For 10% Na2S2O3Solution and saturated salt solution successively wash, and anhydrous sodium sulfate is dry.Filtering, is spin-dried for, and crosses silica gel post separation (petrol ether/ethyl acetate=10/1, v/v) obtains white solid product 3l (147.3mg, 74%).The characterization number of the compound According to as follows:1H NMR(400MHz,DMSO-d6): δ (ppm) 11.52 (s, 1H), 8.47 (d, J=7.2Hz, 2H), 7.53 (d, J= 8.0Hz, 1H), 7.47 (d, J=2.4Hz, 1H), 7.40 (t, J=7.2Hz, 2H), 7.34-7.28 (m, 2H), 7.23 (d, J= 7.2Hz, 2H), 7.20-7.13 (m, 2H), 7.00 (t, J=7.2Hz, 1H), 2.86-2.73 (m, 4H), 2.73-2.66 (m, 4H);13C NMR(100MHz,DMSO-d6)δ(ppm)149.1,141.3,137.8,136.1,134.9,130.5,128.6, 127.6,126.8,126.5,125.0,124.7,121.4,119.4,118.9,111.9,110.1,27.5,25.6;HRMS (ESI):m/z[M+H]+calcd for C29H23N2:399.1856;found:399.1855.
Embodiment 27
Compound 1b (1.0mmol, 177mg), compound 2b (0.5mmol, 79.6mg), iodine are added in 25mL seal pipe Simple substance (0.5mmol, 127mg), pyridine (0.5mmol, 39.6mg) and Isosorbide-5-Nitrae-dioxane (2mL), are subsequently placed in 110 DEG C of oil baths In be stirred to react 12h.50mL water quenching reaction is added, (50mL × 3) are extracted with ethyl acetate, later organic phase mass concentration For 10% Na2S2O3Solution and saturated salt solution successively wash, and anhydrous sodium sulfate is dry.Filtering, is spin-dried for, and crosses silica gel post separation (petrol ether/ethyl acetate=10/1, v/v) obtains white solid product 3m (138.6mg, 77%).The characterization number of the compound According to as follows:1H NMR(400MHz,DMSO-d6): δ (ppm) 11.66 (s, 1H), 8.30 (d, J=7.6Hz, 4H), 8.22 (d, J= 2.8Hz, 1H), 8.17 (s, 2H), 7.85 (s, 1H), 7.57 (t, J=7.6Hz, 4H), 7.49 (t, J=7.2Hz, 2H), 7.41 (d, J=8.4Hz, 1H), 7.06 (d, J=8.0Hz, 1H), 2.48 (s, 3H);13C NMR(100MHz,DMSO-d6)δ(ppm) 156.2,145.8,139.3,135.5,129.2,129.0,128.8,126.8,126.6,125.0,123.6,118.8, 115.7,112.8,112.1,21.6;HRMS(ESI):m/z[M+Na]+calcd for C26H20N2Na:383.1519;found: 383.1518。
Embodiment 28
Compound 1b (1.0mmol, 177mg), compound 2c (0.5mmol, 79.6mg), iodine are added in 25mL seal pipe Simple substance (0.5mmol, 127mg), pyridine (0.5mmol, 39.6mg) and Isosorbide-5-Nitrae-dioxane (2mL), are subsequently placed in 110 DEG C of oil baths In be stirred to react 12h.50mL water quenching reaction is added, (50mL × 3) are extracted with ethyl acetate, later organic phase mass concentration For 10% Na2S2O3Solution and saturated salt solution successively wash, and anhydrous sodium sulfate is dry.Filtering, is spin-dried for, and crosses silica gel post separation (petrol ether/ethyl acetate=10/1, v/v) obtains white solid product 3n (113.4mg, 63%).The characterization number of the compound According to as follows:1H NMR(400MHz,DMSO-d6): δ (ppm) 11.64 (s, 1H), 8.31 (d, J=7.2Hz, 4H), 8.23 (d, J= 2.4Hz, 1H), 8.19 (s, 2H), 7.99 (d, J=8.4Hz, 1H), 7.57 (t, J=7.6Hz, 4H), 7.48 (t, J=7.2Hz, 2H), 7.32 (s, 1H), 7.06 (d, J=8.4Hz, 1H), 2.45 (s, 3H);13C NMR(100MHz,DMSO-d6)δ(ppm) 156.2,145.7,139.3,137.7,131.1,129.0,128.7,126.8,126.0,122.7,122.3,119.1, 115.5,113.1,112.1,21.3;HRMS(ESI):m/z[M+Na]+calcd for C26H20N2Na:383.1519;found: 383.1520。
Embodiment 29
Compound 1b (1.0mmol, 177mg), compound 2d (0.5mmol, 79.6mg), iodine are added in 25mL seal pipe Simple substance (0.5mmol, 127mg), pyridine (0.5mmol, 39.6mg) and Isosorbide-5-Nitrae-dioxane (2mL), are subsequently placed in 110 DEG C of oil baths In be stirred to react 12h.50mL water quenching reaction is added, (50mL × 3) are extracted with ethyl acetate, later organic phase mass concentration For 10% Na2S2O3Solution and saturated salt solution successively wash, and anhydrous sodium sulfate is dry.Filtering, is spin-dried for, and crosses silica gel post separation (petrol ether/ethyl acetate=10/1, v/v) obtains white solid product 3o (118.8mg, 66%).The characterization number of the compound According to as follows:1H NMR(400MHz,DMSO-d6):δ(ppm)11.75(s,1H),8.34–8.29(m,5H),8.21(s,2H), 7.95 (d, J=8.0Hz, 1H), 7.57 (t, J=7.4Hz, 4H), 7.49 (t, J=7.2Hz, 2H), 7.14 (t, J=7.6Hz, 1H), 7.04 (d, J=6.8Hz, 1H), 2.55 (s, 3H);13C NMR(100MHz,DMSO-d6)δ(ppm)156.2,145.7, 139.2,136.7,129.0,128.7,126.8,126.4,124.5,122.5,121.6,120.8,116.9,115.6, 113.7,16.9;HRMS(ESI):m/z[M+H]+calcd for C26H21N2:361.1699;found:361.1696.
Embodiment 30
Compound 1b (1.0mmol, 177mg), compound 2e (0.5mmol, 87.6mg), iodine are added in 25mL seal pipe Simple substance (0.5mmol, 127mg), pyridine (0.5mmol, 39.6mg) and Isosorbide-5-Nitrae-dioxane (2mL), are subsequently placed in 110 DEG C of oil baths In be stirred to react 12h.50mL water quenching reaction is added, (50mL × 3) are extracted with ethyl acetate, later organic phase mass concentration For 10% Na2S2O3Solution and saturated salt solution successively wash, and anhydrous sodium sulfate is dry.Filtering, is spin-dried for, and crosses silica gel post separation (petrol ether/ethyl acetate=10/1, v/v) obtains white solid product 3p (101.5mg, 54%).The characterization number of the compound According to as follows:1H NMR(400MHz,DMSO-d6): δ (ppm) 11.65 (s, 1H), 8.33-8.28 (m, 4H), 8.22 (d, J= 2.4Hz, 1H), 8.16 (s, 2H), 7.56 (t, J=7.4Hz, 4H), 7.51-7.46 (m, 3H), 7.43 (d, J=8.8Hz, 1H), 6.94–6.87(m,1H),3.85(s,3H);13C NMR(100MHz,DMSO-d6)δ(ppm)156.2,154.4,145.7, 139.2,132.3,129.0,128.8,127.1,126.8,125.2,115.5,113.1,113.0,111.6,101.4,55.4; HRMS(ESI):m/z[M+Na]+calcd for C26H20N2NaO:399.1468;found:399.1468.
Embodiment 31
In 25mL seal pipe be added compound 1b (1.0mmol, 177mg), compound 2f (0.5mmol, 125.6mg), Elemental iodine (0.5mmol, 127mg), pyridine (0.5mmol, 39.6mg) and Isosorbide-5-Nitrae-dioxane (2mL), are subsequently placed in 110 DEG C of oil 12h is stirred to react in bath.50mL water quenching reaction is added, (50mL × 3) are extracted with ethyl acetate, organic phase quality is dense later The Na that degree is 10%2S2O3Solution and saturated salt solution successively wash, and anhydrous sodium sulfate is dry.Filtering, is spin-dried for, and crosses silicagel column point White solid product 3q (126.5mg, 56%) is obtained from (petrol ether/ethyl acetate=10/1, v/v).The characterization of the compound Data are as follows:1H NMR(400MHz,DMSO-d6): δ (ppm) 11.69 (s, 1H), 8.29 (d, J=7.2Hz, 4H), 8.24 (d, J =2.8Hz, 1H), 8.12 (s, 2H), 7.61-7.55 (m, 5H), 7.52-7.44 (m, 5H), 7.37-7.28 (m, 3H), 7.04- 6.97(m,1H),5.26(s,2H);13C NMR(100MHz,DMSO-d6)δ(ppm)156.3,153.4,145.7,139.3, 137.9,132.4,129.0,128.7,128.4,127.6,127.3,127.2,126.8,125.1,115.5,113.1(3), 113.0(9),112.7,102.9,69.8;HRMS(ESI):m/z[M+H]+calcd for C32H25N2O:453.1961; found:453.1962。
Embodiment 32
Compound 1b (1.0mmol, 177mg), compound 2g (0.5mmol, 81.6mg), iodine are added in 25mL seal pipe Simple substance (0.5mmol, 127mg), pyridine (0.5mmol, 39.6mg) and Isosorbide-5-Nitrae-dioxane (2mL), are subsequently placed in 110 DEG C of oil baths In be stirred to react 12h.50mL water quenching reaction is added, (50mL × 3) are extracted with ethyl acetate, later organic phase mass concentration For 10% Na2S2O3Solution and saturated salt solution successively wash, and anhydrous sodium sulfate is dry.Filtering, is spin-dried for, and crosses silica gel post separation (petrol ether/ethyl acetate=10/1, v/v) obtains white solid product 3r (125.6mg, 69%).The characterization number of the compound According to as follows:1H NMR(400MHz,DMSO-d6): δ (ppm) 11.91 (s, 1H), 8.37 (s, 1H), 8.33 (d, J=6.8Hz, 4H), 8.16 (s, 2H), 7.83 (d, J=10.0Hz, 1H), 7.56 (d, J=6.4Hz, 5H), 7.49 (d, J=6.4Hz, 2H), 7.10 (t, J=8.8Hz, 1H);13C NMR(100MHz,DMSO-d6)δ(ppm)159.0,156.7,156.3,145.1, 139.2,133.9,129.0,128.7,128.5,126.9,125.0,124.9,115.6,113.7,113.6,113.4, 113.3,110.3,110.0,104.5,104.2;HRMS(ESI):m/z[M+Na]+calcd for C25H17FN2Na: 387.1268;found:387.1271.
Embodiment 33
Compound 1b (1.0mmol, 177mg), compound 2h (0.5mmol, 81.6mg), iodine are added in 25mL seal pipe Simple substance (0.5mmol, 127mg), pyridine (0.5mmol, 39.6mg) and Isosorbide-5-Nitrae-dioxane (2mL), are subsequently placed in 110 DEG C of oil baths In be stirred to react 12h.50mL water quenching reaction is added, (50mL × 3) are extracted with ethyl acetate, later organic phase mass concentration For 10% Na2S2O3Solution and saturated salt solution successively wash, and anhydrous sodium sulfate is dry.Filtering, is spin-dried for, and crosses silica gel post separation (petrol ether/ethyl acetate=10/1, v/v) obtains white solid product 3s (123.7mg, 68%).The characterization number of the compound According to as follows:1H NMR(400MHz,DMSO-d6):δ(ppm)11.87(s,1H),8.37–8.28(m,5H),8.20(s,2H), 8.16-8.09 (m, 1H), 7.57 (t, J=7.6Hz, 4H), 7.49 (t, J=7.2Hz, 2H), 7.38-7.32 (m, 1H), 7.14- 7.06(m,1H);13C NMR(100MHz,DMSO-d6)δ(ppm)160.2,157.8,156.3,145.1,139.2,137.3, 137.2,129.0,128.7,126.9,121.7,120.7,120.6,115.7,113.6,109.0,108.8,98.4,98.2; HRMS(ESI):m/z[M+Na]+calcd for C25H17FN2Na:387.1268;found:387.1270.
Embodiment 34
Compound 1b (1.0mmol, 177mg), compound 2i (0.5mmol, 89.8mg), iodine are added in 25mL seal pipe Simple substance (0.5mmol, 127mg), pyridine (0.5mmol, 39.6mg) and Isosorbide-5-Nitrae-dioxane (2mL), are subsequently placed in 110 DEG C of oil baths In be stirred to react 12h.50mL water quenching reaction is added, (50mL × 3) are extracted with ethyl acetate, later organic phase mass concentration For 10% Na2S2O3Solution and saturated salt solution successively wash, and anhydrous sodium sulfate is dry.Filtering, is spin-dried for, and crosses silica gel post separation (petrol ether/ethyl acetate=10/1, v/v) obtains white solid product 3t (123.8mg, 65%).The characterization number of the compound According to as follows:1H NMR(400MHz,DMSO-d6): δ (ppm) 11.98 (s, 1H), 8.34 (d, J=2.4Hz, 1H), 8.31 (d, J= 8.0Hz, 4H), 8.14 (s, 2H), 8.04 (s, 1H), 7.56 (t, J=7.6Hz, 5H), 7.48 (t, J=7.2Hz, 2H), 7.28- 7.20(m,1H);13C NMR(100MHz,DMSO-d6)δ(ppm)156.4,144.9,139.2,135.7,129.1,128.7, 128.2,126.9,125.8,125.1,122.0,118.4,115.9,113.9,113.3;HRMS(ESI):m/z[M+Na]+ calcd for C25H17ClN2Na:403.0972;found:403.0976.
Embodiment 35
Compound 1b (1.0mmol, 177mg), compound 2j (0.5mmol, 89.8mg), iodine are added in 25mL seal pipe Simple substance (0.5mmol, 127mg), pyridine (0.5mmol, 39.6mg) and Isosorbide-5-Nitrae-dioxane (2mL), are subsequently placed in 110 DEG C of oil baths In be stirred to react 12h.50mL water quenching reaction is added, (50mL × 3) are extracted with ethyl acetate, later organic phase mass concentration For 10% Na2S2O3Solution and saturated salt solution successively wash, and anhydrous sodium sulfate is dry.Filtering, is spin-dried for, and crosses silica gel post separation (petrol ether/ethyl acetate=10/1, v/v) obtains white solid product 3u (112.4mg, 59%).The characterization number of the compound According to as follows:1H NMR(400MHz,DMSO-d6): δ (ppm) 11.98 (s, 1H), 8.34 (d, J=2.4Hz, 1H), 8.31 (d, J= 8.0Hz, 4H), 8.14 (s, 2H), 8.04 (s, 1H), 7.56 (t, J=7.6Hz, 5H), 7.48 (t, J=7.2Hz, 2H), 7.28- 7.20(m,1H);13C NMR(100MHz,DMSO-d6)δ(ppm)156.4,144.9,139.2,135.7,129.1,128.7, 128.2,126.9,125.8,125.1,122.0,118.4,115.9,113.9,113.3;HRMS(ESI):m/z[M+Na]+ calcd for C25H17ClN2Na:403.0972;found:403.0976.
Embodiment 36
In 25mL seal pipe be added compound 1b (1.0mmol, 177mg), compound 2k (0.5mmol, 101.6mg), Elemental iodine (0.5mmol, 127mg), pyridine (0.5mmol, 39.6mg) and Isosorbide-5-Nitrae-dioxane (2mL), are subsequently placed in 110 DEG C of oil 12h is stirred to react in bath.50mL water quenching reaction is added, (50mL × 3) are extracted with ethyl acetate, organic phase quality is dense later The Na that degree is 10%2S2O3Solution and saturated salt solution successively wash, and anhydrous sodium sulfate is dry.Filtering, is spin-dried for, and crosses silicagel column point White solid product 3v (82.8mg, 41%) is obtained from (petrol ether/ethyl acetate=10/1, v/v).The characterization number of the compound According to as follows:1H NMR(400MHz,DMSO-d6): δ (ppm) 12.19 (s, 1H), 8.53 (d, J=2.4Hz, 1H), 8.32 (d, J= 7.6Hz, 4H), 8.23-8.17 (m, 4H), 7.85-7.81 (m, 1H), 7.57 (t, J=7.4Hz, 4H), 7.49 (t, J= 7.2Hz,2H),3.89(s,3H);13C NMR(100MHz,DMSO-d6)δ(ppm)167.0,156.4,144.8,139.1, 136.5,130.2,129.1,128.8,128.2,126.9,122.9,121.1,119.4,115.9,114.1,113.9,52.0; HRMS(ESI):m/z[M+H]+calcd for C27H21N2O2:405.1598;found:405.1596.
Embodiment 37
Compound 1b (1.0mmol, 177mg), compound 2l (0.5mmol, 95mg), iodine list are added in 25mL seal pipe Matter (0.5mmol, 127mg), pyridine (0.5mmol, 39.6mg) and Isosorbide-5-Nitrae-dioxane (2mL), are subsequently placed in 110 DEG C of oil baths It is stirred to react 12h.50mL water quenching reaction is added, (50mL × 3) are extracted with ethyl acetate, organic phase is with mass concentration later 10% Na2S2O3Solution and saturated salt solution successively wash, and anhydrous sodium sulfate is dry.Filtering, is spin-dried for, and crosses silica gel post separation (stone Oily ether/ethyl acetate=10/1, v/v) obtain white solid product 3w (138.8mg, 71%).The characterize data of the compound is such as Under:1H NMR(400MHz,DMSO-d6): δ (ppm) 12.47 (s, 1H), 8.58 (d, J=8.0Hz, 1H), 8.40 (d, J= 2.8Hz, 1H), 8.36-8.30 (m, 4H), 8.25-8.18 (m, 3H), 7.56 (t, J=7.4Hz, 4H), 7.48 (t, J= 7.2Hz, 2H), 7.42 (t, J=8.0Hz, 1H);13C NMR(100MHz,DMSO-d6)δ(ppm)156.4,143.9,139.0, 133.0,129.4,129.3,129.1,129.0,128.7,128.1,127.0,120.2,119.3,116.6,115.3;HRMS (ESI):m/z[M+H]+calcd for C25H18N3O2:392.1394;found:392.1394.
Embodiment 38
Compound 1b (1.0mmol, 177mg), compound 2m (0.5mmol, 79.6mg), iodine are added in 25mL seal pipe Simple substance (0.5mmol, 127mg), pyridine (0.5mmol, 39.6mg) and Isosorbide-5-Nitrae-dioxane (2mL), are subsequently placed in 110 DEG C of oil baths In be stirred to react 12h.50mL water quenching reaction is added, (50mL × 3) are extracted with ethyl acetate, later organic phase mass concentration For 10% Na2S2O3Solution and saturated salt solution successively wash, and anhydrous sodium sulfate is dry.Filtering, is spin-dried for, and crosses silica gel post separation (petrol ether/ethyl acetate=10/1, v/v) obtains white solid product 3x (124.2mg, 69%).The characterization number of the compound According to as follows:1H NMR(400MHz,CDCl3): δ (ppm) 8.32 (d, J=7.6Hz, 4H), 8.15 (d, J=7.6Hz, 1H), 8.02 (s, 2H), 7.63 (t, J=7.4Hz, 4H), 7.58-7.52 (m, 2H), 7.47-7.34 (m, 4H), 3.79 (s, 3H);13C NMR (100MHz,CDCl3)δ(ppm)157.1,144.7,139.8,137.6,128.7,128.6,128.0,127.0,125.6, 122.3,120.6,119.7,116.5,114.1,109.9,32.8;HRMS(ESI):m/z[M+H]+calcd for C26H21N2: 361.1699;found:361.1701.
Embodiment above describes basic principles and main features of the invention and advantage, the technical staff of the industry should Understand, the present invention is not limited to the above embodiments, and the above embodiments and description only describe originals of the invention Reason, under the range for not departing from the principle of the invention, various changes and improvements may be made to the invention, these changes and improvements are each fallen within In the scope of protection of the invention.

Claims (5)

1. a kind of synthetic method of 3- (4- pyridine) Benzazole compounds, it is characterised in that specific steps are as follows: by acetic acid oxime esters Compound 1 and 3- formyl indole class compound 2 are dissolved in solvent, catalyst and nitrogenous organic base are then added, in seal pipe In reacted in 100-130 DEG C target product 3- (4- pyridine) Benzazole compounds 3 be made, the reaction equation in the synthetic method Are as follows:
Wherein R1For phenyl, substituted-phenyl, 2- naphthalene or thienyl, which is 3,4- methylenedioxyphenyl, 3,4- bis- Chloro phenyl or mono-substituted benzenes base, the substituent group on mono-substituted benzenes base phenyl ring are methyl, methoxyl group, nitro, chlorine or bromine, R2 For hydrogen, methyl, methoxyl group, methoxybenzyl, fluorine, chlorine, carbomethoxy or nitro, R3For hydrogen or methyl, solvent is toluene, chlorobenzene, second Nitrile, Isosorbide-5-Nitrae-dioxane, tetrahydrofuran or n,N-Dimethylformamide, catalyst be elemental iodine, N- N-iodosuccinimide or Ammonium iodide, nitrogenous organic base are triethylamine, diethylamine, pyridine, Isosorbide-5-Nitrae-diazabicylo [2.2.2] octane, 1,8- diaza two 11 carbon -7- alkene of ring or quinoline.
2. the synthetic method of 3- (4- pyridine) Benzazole compounds according to claim 1, it is characterised in that: the acetic acid The molar ratio of oxime ester compound 1,3- formyl indole or derivatives thereof 2, catalyst and nitrogenous organic base is 2:1:1: 1, the charge ratio of acetic acid oxime ester compound 1 and solvent is 1mmol:2mL.
3. a kind of synthetic method of 3- (4- pyridine) Benzazole compounds, it is characterised in that specific steps are as follows: by acetic acid oxime esters Compound 1l and 3- formyl indole 2a is dissolved in solvent Isosorbide-5-Nitrae-dioxane, and catalyst iodine simple substance and nitrogenous organic is then added Alkali pyridine reacts in 110 DEG C in seal pipe and target product quinoline -4- Carbox amide 3l is made, in the synthetic method Reaction equation are as follows:
4. the synthetic method of 3- (4- pyridine) Benzazole compounds according to claim 3, it is characterised in that: the acetic acid The molar ratio of oxime ester compound 1l, 3- formyl indole 2a, catalyst iodine simple substance and nitrogenous organic base pyridine are 2:1: 1:1, acetic acid oxime ester compound 1l and solvent Isosorbide-5-Nitrae-dioxane charge ratio are 1mmol:2mL.
5. the synthetic method of 3- (4- pyridine) Benzazole compounds according to claim 1 or 3, it is characterised in that the 3- (4- pyridine) Benzazole compounds 3 are one of following compounds:
CN201811073559.1A 2018-09-14 2018-09-14 Synthetic method of 3- (4-pyridine) indole compound Active CN108976198B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811073559.1A CN108976198B (en) 2018-09-14 2018-09-14 Synthetic method of 3- (4-pyridine) indole compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811073559.1A CN108976198B (en) 2018-09-14 2018-09-14 Synthetic method of 3- (4-pyridine) indole compound

Publications (2)

Publication Number Publication Date
CN108976198A true CN108976198A (en) 2018-12-11
CN108976198B CN108976198B (en) 2020-06-26

Family

ID=64546204

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811073559.1A Active CN108976198B (en) 2018-09-14 2018-09-14 Synthetic method of 3- (4-pyridine) indole compound

Country Status (1)

Country Link
CN (1) CN108976198B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113527536A (en) * 2020-04-21 2021-10-22 杭州德柯医疗科技有限公司 Fluorine-containing polysaccharide high molecular compound and preparation method thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113527536A (en) * 2020-04-21 2021-10-22 杭州德柯医疗科技有限公司 Fluorine-containing polysaccharide high molecular compound and preparation method thereof
CN113527536B (en) * 2020-04-21 2024-03-22 杭州德柯医疗科技有限公司 Fluorine-containing polysaccharide high molecular compound and preparation method thereof

Also Published As

Publication number Publication date
CN108976198B (en) 2020-06-26

Similar Documents

Publication Publication Date Title
He et al. ZnBr 2-Mediated oxidative spiro-bromocyclization of propiolamide for the synthesis of 3-bromo-1-azaspiro [4.5] deca-3, 6, 9-triene-2, 8-dione
CN108484477B (en) Synthesis method of 5-acyl benzo [ a ] carbazole compound
CN103508899B (en) Method for preparing ticagrelor key intermediate and racemate thereof and special intermediate for implementing method
CN107698586A (en) It is a kind of that the method for preparing Pyridine-quinazolinocompound compound is catalyzed by copper compound
CN104926811B (en) The synthetic method of 3-cyanoimidazole also [1,2-a] pyridine compounds and application thereof
CN109180653A (en) A kind of copper catalysis prepares benzofuran-azoles method
CN111303028B (en) 4-cyano-2-difluoromethyl substituted quinoline compound and synthetic method thereof
CN105801575A (en) Synthetic method of imidazo[1,2-a]pyridine
CN108640917A (en) A kind of synthetic method of indoles simultaneously [2,1-a] isoquinoline compound
CN108610278B (en) Synthetic method of 6-amino-5-acyl benzo [ a ] carbazole compound
CN106117216A (en) A kind of method of atmospheric high efficiency synthesis 6H iso-indoles [2,1 a] indole 6 ketone compounds
CN108976198A (en) A kind of synthetic method of 3- (4- pyridine) Benzazole compounds
CN107602452B (en) Synthetic method of 3-acyl pyridine compound
CN102216274A (en) Process for making (r) -3-(2,3-dihydroxypropyl)-6-fluoro-5-(2-flouro-4-iodophenylamino)-8-methylpyrido[2,3-d]pyrimidine-4,7(3h,8h)-dione and intermediates thereof
CN111269156A (en) Synthesis method of 1,2, 4-tricarbonyl sulfoxide ylide compound
CN113912609B (en) Preparation method of natural alkaloid tryptanthrin and derivatives thereof
CN110003101B (en) Apatinib intermediate and preparation method thereof
CN104710417A (en) Azaindole derivatives and synthesis method thereof
CN108314642A (en) A kind of synthetic method of 2- picolines class compound
CN105237466B (en) A kind of method for synthesizing three substituted pyridine derivatives
CN108929262B (en) Synthetic method of benzo [ a ] carbazole compound
CN106674105A (en) C5-site selective halogenation method for amide quinoline derivative
CN102702069B (en) 2-cyano-substituted indole compound and synthetic method thereof
CN102718694B (en) 3-cyan substituted indole compound and synthetic method thereof
CN107501180B (en) Synthesis method of quinoline-4-formamide compound

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant